PERINATAL OUTCOME IN PREGNANCIES WITH MECONIUM STAINED AMNIOTIC FLUID: A PROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Keywords
.
Abstract
IIntroduction: Meconium-stained amniotic fluid MSAF) is observed in 12-16% of all deliveries and can indicate physiological maturation or fetal distress. Thick meconium is associated with adverse perinatal outcomes, including meconium aspiration syndrome MAS , respiratory distress, and increased neonatal morbidity.
References
1. Thobbi VA, Inamdar SM. Meconium-stained amniotic fluid: A clinical review. Int J Clin Obstet Gynaecol. 2020;4 2 45 50.
2. Mathews DD, Warshaw JB. Meconium-stained amniotic fluid: Clinical significance. Am J Obstet Gynecol. 2021;224 3 345 50.
3. Wiswell TE et al. Management of infants born through meconium-stained amniotic fluid: An evidence-based approach. Pediatrics. 2020;146 3 e20200189
2. Mathews DD, Warshaw JB. Meconium-stained amniotic fluid: Clinical significance. Am J Obstet Gynecol. 2021;224 3 345 50.
3. Wiswell TE et al. Management of infants born through meconium-stained amniotic fluid: An evidence-based approach. Pediatrics. 2020;146 3 e20200189
Article Sidebar
Published
Mar 28, 2025
Article Details
How to Cite
Pallabi Sengupta, Jaydeb Mandal , Raju Gopal Saha, Debadrita Das ,Mallika Hembram , Bibek Mohan Rakshit. (2025). PERINATAL OUTCOME IN PREGNANCIES WITH MECONIUM STAINED AMNIOTIC FLUID: A PROSPECTIVE OBSERVATIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 32(2), 890-895. https://doi.org/10.53555/ckdydm85
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Pallabi Sengupta, Jaydeb Mandal , Raju Gopal Saha, Debadrita Das ,Mallika Hembram , Bibek Mohan Rakshit. (2025). PERINATAL OUTCOME IN PREGNANCIES WITH MECONIUM STAINED AMNIOTIC FLUID: A PROSPECTIVE OBSERVATIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 32(2), 890-895. https://doi.org/10.53555/ckdydm85